These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 35138735
21. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M, Konzen C, Kreutz R, Garbe E. Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038 [Abstract] [Full Text] [Related]
22. Who gets dipyrone (metamizole) in Germany? Prescribing by age, sex and region. Hoffmann F, Meinecke P, Freitag MH, Glaeske G, Schulze J, Schmiemann G. J Clin Pharm Ther; 2015 Jun; 40(3):285-8. PubMed ID: 25776531 [Abstract] [Full Text] [Related]
28. Unmasking of Metamizole-induced Liver Injury by Simult aneous Development of Characteristic Agranulocytosis. Lutz M, Grünewald I, Lenze F, Heinzow H, Ullerich H, Kabar I, Schmidt HH, Tepasse PR. Curr Drug Saf; 2023 Jun; 18(3):404-412. PubMed ID: 35670337 [Abstract] [Full Text] [Related]
29. Agranulocytosis associated with dipyrone (metamizol). Ibáñez L, Vidal X, Ballarín E, Laporte JR. Eur J Clin Pharmacol; 2005 Jan; 60(11):821-9. PubMed ID: 15580488 [Abstract] [Full Text] [Related]
30. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis]. Stamer UM, Gundert-Remy U, Biermann E, Erlenwein J, Meiβner W, Wirz S, Stammschulte T. Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404 [Abstract] [Full Text] [Related]
31. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose. Allgaier R, Kandulski A, Gülow K, Maier L, Müller M, Tews HC. Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798 [Abstract] [Full Text] [Related]
32. Safety of metamizole: a systematic review of the literature. Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J. J Clin Pharm Ther; 2016 Oct; 41(5):459-77. PubMed ID: 27422768 [Abstract] [Full Text] [Related]
34. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis. Bäckström M, Hägg S, Mjörndal T, Dahlqvist R. Pharmacoepidemiol Drug Saf; 2002 Oct; 11(3):239-45. PubMed ID: 12051124 [Abstract] [Full Text] [Related]
37. Metamizole for postoperative pain therapy in 1177 children: A prospective, multicentre, observational, postauthorisation safety study. Fieler M, Eich C, Becke K, Badelt G, Leimkühler K, Messroghli L, Boethig D, Sümpelmann R. Eur J Anaesthesiol; 2015 Dec; 32(12):839-43. PubMed ID: 26086280 [Abstract] [Full Text] [Related]
38. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients. Lerman TT, Sagi M, Shafir Y, Sheena L, Cohen E, Goldberg E, Krause I. Br J Clin Pharmacol; 2021 Jul; 87(7):2902-2906. PubMed ID: 33332642 [Abstract] [Full Text] [Related]
40. [The use of metamizole as a risk factor in the occurrence of agranulocytosis]. Vlakhov V, Bakracheva N, Popova L. Vutr Boles; 1988 Jul; 27(2):80-5. PubMed ID: 3046147 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]